Tenable announced it has signed an agreement to acquire Cymptom, a vendor in attack path management. Cymptom enables organizations to continuously test and evaluate threats according to the MITRE ATT&CK framework and the hacker’s attack perspective, without the use of agents or running simulated attacks.
Combining Tenable’s market-leading coverage of vulnerabilities and misconfigurations with Cymptom’s unique attack path analysis and prioritization capabilities will enable security teams to preemptively focus response ahead of and during attacks.
After closing, Cymptom’s agentless platform will be integrated into Tenable’s threat and vulnerability data to provide an always-on view of every attack path. Attack path analysis will bring additional context and prioritization capabilities to Tenable’s platform, with a unified view of assets and vulnerabilities. Cymptom was founded in 2019 and is led by Israeli Defense Force veterans and white hat hackers. The terms of the deal were not disclosed and the acquisition is expected to close in the first quarter of 2022.
“Risk prioritization has become a cornerstone of modern cybersecurity. By correlating software vulnerabilities and misconfigurations with network and access data, Cymptom can immediately identify exploitable attack and breach pathways,” said Nico Popp, chief product officer, Tenable. “Following closing of the deal, these compelling analytics will be integrated into Tenable.ep, Tenable’s Exposure Platform, and augment the prioritization, benchmarking, trending and other capabilities which are part of Lumin and available via Tenable.ep.”
“Cymptom and Tenable share a common vision that modern vulnerability management combined with a deep and sophisticated understanding of attackers’ perspectives is a powerful weapon in stopping breaches and reducing risk to the enterprise. Tenable helps its customers identify the flaws attackers will exploit to gain a foothold and elevate privileges. Cymptom’s capabilities will augment Tenable’s ability to predict the most likely paths, identify choke points and mitigate flaws before they can be exploited,” said Itamar Mizrahi, CEO, Cymptom. “We are excited to accelerate our mission and eager to work with Tenable’s global team.”